Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis
Authors
Keywords
-
Journal
Archives of Cardiovascular Diseases
Volume 116, Issue 10, Pages 460-466
Publisher
Elsevier BV
Online
2023-08-13
DOI
10.1016/j.acvd.2023.07.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myocarditis
- (2022) Cristina Basso NEW ENGLAND JOURNAL OF MEDICINE
- Recognition and Initial Management of Fulminant Myocarditis
- (2020) Robb D. Kociol et al. CIRCULATION
- Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis
- (2020) Federica Bello et al. RHEUMATOLOGY
- Management of Myocarditis-Related Cardiomyopathy in Adults
- (2019) Carsten Tschöpe et al. CIRCULATION RESEARCH
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry
- (2018) Enrico Ammirati et al. CIRCULATION
- Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis
- (2018) Max-Paul Winter et al. HEART FAILURE REVIEWS
- National Trends and Outcomes of Endomyocardial Biopsy for Patients With Myocarditis: From the National Inpatient Sample Database
- (2018) Ayman Elbadawi et al. JOURNAL OF CARDIAC FAILURE
- Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis
- (2018) Christos P. Kotanidis et al. JACC-Cardiovascular Imaging
- Myocarditis: An Interleukin-1-Mediated Disease?
- (2018) Giacomo De Luca et al. Frontiers in Immunology
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
- (2018) Vanessa M. Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Anakinra in Fulminant Myocarditis
- (2016) Yoshihiro Noji CRITICAL CARE MEDICINE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Rate and patient features associated with recurrence of acute myocarditis
- (2014) Ville Kytö et al. European Journal of Internal Medicine
- Formation of the inflammasome in acute myocarditis
- (2014) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- Myocarditis
- (2011) Sandeep Sagar et al. LANCET
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Myocarditis
- (2009) Leslie T. Cooper NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now